tiprankstipranks
Mayne Pharma Group (AU:MYX)
ASX:MYX
Australian Market

Mayne Pharma Group (MYX) Financial Statements

Compare
27 Followers

Mayne Pharma Group Financial Overview

Mayne Pharma Group's market cap is currently $439.54M. The company's EPS TTM is AU$-2.144; its P/E ratio is ―; Mayne Pharma Group is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78MAU$ 456.99M
Gross ProfitAU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02MAU$ 140.94M
Operating IncomeAU$ -45.86MAU$ -186.44MAU$ -121.88MAU$ 1.36MAU$ -12.13M
EBITDAAU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40MAU$ -34.03M
Net IncomeAU$ -174.23MAU$ -316.42MAU$ -281.29MAU$ -208.42MAU$ -92.79M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 149.28MAU$ 229.24MAU$ 97.08MAU$ 98.35MAU$ 138.19M
Total AssetsAU$ 1.14BAU$ 1.25BAU$ 1.30BAU$ 1.48BAU$ 1.84B
Total DebtAU$ 38.82MAU$ 47.51MAU$ 413.67MAU$ 346.82MAU$ 398.05M
Net DebtAU$ -71.25MAU$ -54.21MAU$ 316.59MAU$ 248.47MAU$ 259.85M
Total LiabilitiesAU$ 688.99MAU$ 613.77MAU$ 764.89MAU$ 706.56MAU$ 799.91M
Stockholders' EquityAU$ 454.19MAU$ 634.36MAU$ 545.88MAU$ 768.36MAU$ 1.04B
Cash Flow
Free Cash FlowAU$ -36.16MAU$ -262.71MAU$ -28.47MAU$ 22.16MAU$ 52.66M
Operating Cash FlowAU$ -15.30MAU$ -43.12MAU$ -16.62MAU$ 47.26MAU$ 99.78M
Investing Cash FlowAU$ 53.45MAU$ 473.49MAU$ -28.53MAU$ -49.25MAU$ -55.87M
Financing Cash FlowAU$ -19.85MAU$ -431.48MAU$ 37.01MAU$ -28.83MAU$ 4.52M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

Mayne Pharma Group Debt to Assets

Mayne Pharma Group Cash Flow

Mayne Pharma Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis